Wilson; David Matthew

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wilson; David Matthew.The latest application filed is for "benzoimidazole derivatives as pad4 inhibitors".

Company Profile

1.32.54

Wilson; David Matthew - Madrid ES
Wilson; David Matthew - Stevenage GB
Wilson; David Matthew - Harlow GB
Wilson; David Matthew - Hertfordshire GB
Wilson; David Matthew - Essex GB
Wilson; David Matthew - Harlow Essex GB
Wilson; David Matthew - King of Prussia PA
Wilson; David Matthew - Herts GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Benzoimidazole derivatives as PAD4 inhibitors Grant 10,815,218 - Amans , et al. October 27, 2	2020-10-27
Benzoimidazole Derivatives As Pad4 Inhibitors App 20200095227 - AMANS; Dominique ; et al.	2020-03-26
Benzoimidazole derivatives as PAD4 inhibitors Grant 10,407,407 - Amans , et al. Sept	2019-09-10
Benzoimidazole Derivatives As Pad4 Inhibitors App 20180297983 - Amans; Dominique ; et al.	2018-10-18
2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors Grant 10,039,755 - Atkinson , et al. August 7, 2	2018-08-07
2-(azaindol-2-yl) Benzimidazoles As Pad4 Inhibitors App 20180161316 - Atkinson; Stephen John ; et al.	2018-06-14
Thiotriazole Compound And Its Use In Parasitic Protozoal Infections App 20170368034 - DIAZ HERNANDEZ; Beatriz ; et al.	2017-12-28
2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors Grant 9,833,449 - Atkinson , et al. December 5, 2	2017-12-05
2- (azaindol-2-yl) Benzimidazoles As Pad4 Inhibitors App 20170119750 - Atkinson; Stephen John ; et al.	2017-05-04
Compound (S) and (R)-N-(2-fluoropyridin-4-yl)-3-methyl-2-(5-methyl-2,4-dioxo-1,2-dihydropy- rido[3,4-d]pyrimidin-3(4H)-yl)butanamide and use Grant 9,624,219 - Coteron Lopez , et al. April 18, 2	2017-04-18
2-(azaindol-2-yl) benz imidazoles as PAD4 inhibitors Grant 9,518,054 - Atkinson , et al. December 13, 2	2016-12-13
Novel Compounds App 20160355505 - ATKINSON; Francis Louis ; et al.	2016-12-08
Compound (S) and (R)-N-(2-fluoropyridin-4-yl)-3-methyl-2-(5-methyl-2,4-dioxo-1,2-dihydropy- rido[3,4-d]pyrimidin-3(4H)-yl)butanamide and use App 20160311821 - COTERON LOPEZ; Jose-Miguel ; et al.	2016-10-27
Compounds Grant 9,447,074 - Atkinson , et al. September 20, 2	2016-09-20
2 - (azaindol-2-yl) Benz Imidazoles As Pad4 Inhibitors App 20160009716 - Atkinson; Stephen John ; et al.	2016-01-14
2-(azaindol-2-yl)benzimidazoles as PAD4 inhibitors Grant 9,127,003 - Atkinson , et al. September 8, 2	2015-09-08
Inhibitors Of Bromodomain-containing Protein Pcaf For The Treatment Of Autoimmune And Inflammatory Diseases Or For The Treatment Of Cancer App 20150203851 - Kruidenier; Laurens ; et al.	2015-07-23
2-(azaindol-2-yl)benzimidazoles As Pad4 Inhibitors App 20150175600 - Atkinson; Stephen John ; et al.	2015-06-25
Novel Compounds App 20150166508 - ATKINSON; Francis Louis ; et al.	2015-06-18
Compounds Grant 8,993,560 - Atkinson , et al. March 31, 2	2015-03-31
Tetrahydroquinoline derivatives and their pharmaceutical use Grant 8,697,725 - Demont , et al. April 15, 2	2014-04-15
Method of treatment based on ATAD2 inhibitors Grant 8,691,747 - Kruidenier , et al. April 8, 2	2014-04-08
Method of Treatment App 20140024558 - Lee; Kevin ; et al.	2014-01-23
7-(1H-pyrazol-4-yl)-1,6-naphthyridine compounds as Syk inhibitors Grant 8,633,319 - Atkinson , et al. January 21, 2	2014-01-21
Pyrido[3,4-b]pyrazine Derivatives As Syk Inhibitors App 20140005188 - Atkinson; Francis Louis ; et al.	2014-01-02
Pyridinyl- And Pyrazinyl-methyloxy-aryl Derivatives Useful As Inhibitors Of Spleen Tyrosine Kinase (syk) App 20140005177 - Atkinson; Francis Louis ; et al.	2014-01-02
Method of Treatment Based on ATAD2 Inhibitors App 20130224204 - Kruidenier; Laurens ; et al.	2013-08-29
7-(lH-PYRAZOL-4-YL)-1,6-NAPHTHYRIDINE COMPOUNDS AS SYK INHIBITORS App 20130040984 - Atkinson; Francis Louis ; et al.	2013-02-14
Novel Compounds App 20120232061 - Atkinson; Francis Louis ; et al.	2012-09-13
Tetrahydroquinoline Derivatives And Their Pharmaceutical Use App 20120208798 - Demont; Emmanuel Hubert ; et al.	2012-08-16
Method Of Treatment App 20120202875 - Lee; Kevin ; et al.	2012-08-09
Benzazepine derivatives for the treatment of neurological disorders Grant 8,207,331 - Bamford , et al. June 26, 2	2012-06-26
Pyrazolo [3,4-D]azepine derivatives as histamine H3 antagonists Grant 7,888,347 - Bamford , et al. February 15, 2	2011-02-15
Benzazepine derivatives for the treatment of neurological disorders Grant 7,799,773 - Bamford , et al. September 21, 2	2010-09-21
Benzazepine Derivatives For The Treatment of Neurological Disorders App 20100145040 - Bamford; Mark James ; et al.	2010-06-10
Benzazepine derivatives for the treatment of neurological disorders Grant 7,704,994 - Sehmi , et al. April 27, 2	2010-04-27
Benzazepine derivatives for the treatment of neurological disorders Grant 7,696,193 - Sehmi , et al. April 13, 2	2010-04-13
Substituted Piperazines, (1,4) Diazepines, And 2,5-diazabicyclo (2.2.1) Heptanes As Histamine H1 And/or H3 Antagonists Or Histamine H3 Reverse Antagonists App 20100075953 - Ancliff; Rachael ; et al.	2010-03-25
Indenyl Derivatives And Use Thereof For The Treatment Of Neurological Disorders App 20090306052 - Wilson; David Matthew	2009-12-10
Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists Grant 7,615,550 - Heightman , et al. November 10, 2	2009-11-10
2-phenyl-5-amino-1,3,4-oxadiazoles And Their Use As Nicotinic Acetylcholine Receptor Ligands App 20090105217 - Coppo; Frank Teen ; et al.	2009-04-23
Benzazepine Derivatives For The Treatment Of Neurological Disorders App 20090105226 - BAMFORD; Mark James ; et al.	2009-04-23
Pyridine derivatives as Raf kinase inhibitors Grant 7,452,906 - Bamford , et al. November 18, 2	2008-11-18
Piperazinone Derivatives Useful as Histamine H3 Receptor Antagonists and/or Inverse Agonists App 20080275027 - Ancliff; Rachael Ann ; et al.	2008-11-06
Pyridylfurans and pyrroles as Raf kinase inhibitors Grant 7,446,106 - Dean , et al. November 4, 2	2008-11-04
Compounds App 20080207638 - Ancliff; Rachael Ann ; et al.	2008-08-28
Pyrazolo [3,4-D]Azepine Derivatives as Histamine H3 Antagonists App 20080176832 - Bamford; Mark James ; et al.	2008-07-24
Fused Thiazole Derivatives Having Affinity for the Histamine H3 Receptor App 20080161289 - Bailey; Nicholas ; et al.	2008-07-03
Pyridine substituted furan derivatives as Raf kinase inhibitors Grant 7,375,105 - Dean , et al. May 20, 2	2008-05-20
Imidazole-2-Carboxamide Derivatives as Raf Kinase Inhibitors App 20080108615 - Dean; David Kenneth ; et al.	2008-05-08
Imidazopyridine derivatives as kinase inhibitors Grant 7,348,339 - Bailey , et al. March 25, 2	2008-03-25
Tetrahydrobenzazepines as Histamine H3 Receptor Ligands App 20080009479 - Heightman; Thomas Daniel ; et al.	2008-01-10
Benzazepine Derivatives For The Treatment Of Neurological Disorders App 20070299056 - Bamford; Mark James ; et al.	2007-12-27
Nitrogen-containing heterocyclic compounds and their use as Raf inhibitors Grant 7,297,693 - Bamford , et al. November 20, 2	2007-11-20
Pyridylfurans and pyrroles as Raf kinase inhibitors Grant 7,297,694 - Dean , et al. November 20, 2	2007-11-20
Heterocycle-carboxamide Derivatives As Raf Kinase Inhibitors App 20070244123 - Dean; David Kenneth ; et al.	2007-10-18
Imidazole-2-carboxamide derivatives as Raf kinase inhibitors Grant 7,282,500 - Dean , et al. October 16, 2	2007-10-16
3-Cylcoalkylbenzazepines as Histamine H3 Antagonists App 20070232590 - Bamford; Mark James ; et al.	2007-10-04
Tetrahydrobenzazepines As Antagonists And/or Reverse Agonists Of The Histamine H3 Receptor App 20070208005 - Parr; Christopher Allan ; et al.	2007-09-06
Benzazepine derivatives for the treatment of neurological and psychiatric disorders App 20070185089 - Bamford; Mark James ; et al.	2007-08-09
Imidazole Derivatives As Raf Kinase Inhibitors App 20070135433 - DEAN; David Kenneth ; et al.	2007-06-14
Imidazole derivatives as Raf kinase inhibitors Grant 7,199,137 - Dean , et al. April 3, 2	2007-04-03
Benzazepine derivatives as histamine h3 antagonists App 20070060566 - Bailey; Nicholas ; et al.	2007-03-15
Compounds App 20060293298 - Bamford; Mark James ; et al.	2006-12-28
Chemical compounds App 20060241149 - Adams; Jerry Leroy ; et al.	2006-10-26
Compounds App 20060019964 - Ancliff; Ranchael Ann ; et al.	2006-01-26
Imidazol-2-carboxamide derivatives as raf kinase inhibitors Grant 6,987,119 - Gaiba , et al. January 17, 2	2006-01-17
Imidazopyridine derivatives as kinase inhibitors App 20050197328 - Bailey, Nicholas ; et al.	2005-09-08
Pyridylfurans and pyrroles as raf kinase inhibitors App 20040254186 - Dean, David Kenneth ; et al.	2004-12-16
Pyridine substituted furan derivatives as raf kinase inhibitors App 20040248896 - Dean, David Kenneth ; et al.	2004-12-09
Pyridine derivatives as raf kinase inhibitors App 20040235843 - Bamford, Mark James ; et al.	2004-11-25
Nitrogen-containing heterocyclic compounds and their use as raf inhibitors App 20040209883 - Bamford, Mark James ; et al.	2004-10-21
Pyridylfurans and pyrroles as raf kinase inhibitors App 20040198730 - Dean, David Kenneth ; et al.	2004-10-07
Heterocycle-carboxamide derivatives as raf kinase inhibitors App 20040192689 - Dean, David Kenneth ; et al.	2004-09-30
Imidazole-2-carboxamide derivatives as raf kinase inhibitors App 20040127496 - Dean, David Kenneth ; et al.	2004-07-01
Imidazole derivatives as raf kinase inhibitors App 20040038964 - Dean, David Kenneth ; et al.	2004-02-26
Imidazol-2-carboxamide derivatives as raf kinase inhibitors App 20030134837 - Gaiba, Alessandra ; et al.	2003-07-17